Ying Wang

US Patent:

20100202400, Aug 12, 2010

Filed:

Feb 12, 2009

Appl. No.:

12/370092

Inventors:

Thomas Richardson - South Orange NJ, US
Xinzhou Wu - Monmouth Junction NJ, US
Ying Wang - Easton PA, US
Saurabh Tavildar - Jersey City NJ, US
Junyi Li - Bedminster NJ, US

Assignee:

QUALCOMM Incorporated - San Diego CA

International Classification:

H04W 72/04

US Classification:

370330

Abstract:

Techniques for transmitting signals on shared resources in a manner to detect and/or combat collision are described. In an aspect, a terminal may transmit a signal on a subset of resource elements in a resource block, and at least one null resource element with no signal may be used to detect for collision of the signal. In another aspect, different terminals may simultaneously transmit their signals on different subsets of resource elements in a resource block. These different subsets of resource elements may be pseudo-randomly selected to randomize interference. In one design, a terminal may determine a resource block to use for transmission of a signal, select a subset of the resource elements in the resource block, and transmit the signal on the selected resource elements, e.g., to at least one other terminal for peer-to-peer communication. The signal may be a peer discovery signal, a paging signal, etc.

US Patent:

20220347285, Nov 3, 2022

Filed:

Jun 23, 2020

Appl. No.:

17/621125

Inventors:

- Farmingdale NY, US
John Robert Coleman - Blauvelt NY, US
Charles Stauft - Columbia MD, US
Ying Wang - South Setauket NY, US

Assignee:

CODAGENIX INC. - Farmingdale NY

International Classification:

A61K 39/12
C12N 7/00
A61P 31/14

Abstract:

The present invention provides for modified Flavivirus such as a modified dengue virus type 1, 2, 3, 4, a combination of these, or a tetravalent combination of these. The modification according to various aspects of the invention results in reduced viral protein expression compared to a parent virus, wherein the reduction in expression is the result of recoding one or more regions of the virus. For example, the prM, or envelope (E) region can be recoded. In various embodiments one or more regions are recoded by reducing the codon pair bias or codon usage bias of the protein-encoding sequence. These modified Flaviviruses are used as vaccine compositions to provide a protective immune response.

US Patent:

20220241359, Aug 4, 2022

Filed:

May 14, 2020

Appl. No.:

17/610026

Inventors:

- Farmingdale NY, US
Steffen Mueller - Great Neck NY, US
Charles Stauft - Wheatley Heights NY, US
Ying Wang - South Setauket NY, US

Assignee:

CODAGENIX INC. - Farmingdale NY

International Classification:

A61K 35/768
A61K 45/06
A61K 39/12
C12N 7/00

Abstract:

The present invention is the use of designed recombinant viruses for the treatment of various forms of malignant tumors using attenuated Yellow Fever virus. The method of the present invention is particularly useful for the treatment of malignant tumors in various organs, such as: breast, skin, colon, bronchial passage, epithelial lining of the gastrointestinal, upper respiratory and genito-urinary tracts, liver, prostate and the brain. Astounding remissions in experimental animals have been demonstrated for the treatment of treatment of breast cancer and melanoma.

US Patent:

20210223256, Jul 22, 2021

Filed:

Jan 20, 2021

Appl. No.:

17/153150

Inventors:

- Tarrytown NY, US
Hunter CHEN - New York NY, US
Shao-Chun WANG - Tarryotwn NY, US
Timothy RIEHLMAN - Tarrytown NY, US
Gabriel CARREAU - Troy NY, US
Ying WANG - Tarrytown NY, US

International Classification:

G01N 33/68
G01N 33/58
G01N 27/447

Abstract:

The disclosure relates to methods of analyzing a post-translationally modified protein of interest using electrophoresis, the methods comprising deglycosylating the protein of interest after labeling.

US Patent:

20210000939, Jan 7, 2021

Filed:

Dec 21, 2018

Appl. No.:

16/976220

Inventors:

- Farmingdale NY, US
Steffen Mueller - Great Neck NY, US
Ying Wang - South Setauket NY, US

Assignee:

Codagenix Inc. - Farmingdale NY

International Classification:

A61K 39/12
C12N 7/00
A61P 31/14

Abstract:

The present invention provides for modified Flavivirus such as a modified Zika virus. The modification according to various aspects of the invention results in reduced viral proteins compared to a parent virus, wherein the reduction in expression is the result of recoding one or more regions of the virus. For example, the prM, or envelope (E) region, or the nonstructural protein 3 (NS3) region or both the E and NS3 regions can be recoded. In various embodiments one or more regions are recoded by reducing the codon pair bias or codon usage bias of the protein-encoding sequence. These modified Flavivirus are used as vaccine compositions to provide a protective immune response.

US Patent:

20210006516, Jan 7, 2021

Filed:

Jul 14, 2020

Appl. No.:

16/928190

Inventors:

- Redmond WA, US
Kati Amanda London - New York NY, US
James Bigbee Garver - Redmond WA, US
Ying Wang - Bellevue WA, US
Zhiying Zhang - Redmond WA, US

International Classification:

H04L 12/58
G06K 9/62
G10L 25/60
A63F 13/00
G10L 25/51

Abstract:

Systems and methods may be used to process and output information related to a non-speech vocalization, for example from a user attempting to mimic a non-speech sound. A method may include determine a mimic quality value associated with an audio file by comparing a non-speech vocalization to a prerecorded audio file. For example, the method may include determining an edit distance between the non-speech vocalization and the prerecorded audio file. The method may include assigning a mimic quality value to the audio file based on the edit distance. The method may include outputting the mimic quality value.

Author:

Ying Wang

ISBN #:

0295983655

Author:

Ying Wang

ISBN #:

0444510192

Author:

Ying Wang

ISBN #:

0691010447

Author:

Ying Wang

ISBN #:

7119043234

Author:

Ying Wang

ISBN #:

7530527169

Author:

Ying Wang

ISBN #:

7800249565